The breathless hype “the lastest [sic] vital gastroenterology information on strategies, therapies, equipment” and the out of focus cover artwork give an unfortunate rushed feel to this portable volume, which is indeed rather heterogeneous in content. There are six chapters covering strategic planning for managed care, proton pump inhibitors (PPI), irritable bowel syndrome (IBS), emerging therapies for hepatitis C, colorectal cancer and polyp surveillance, and evolving therapies for colon cancer. Most of the chapters are from the UCLA School of Medicine, some from the East coast and …